Invention Grant
- Patent Title: Heterobicyclic compounds and their use for the treatment of tuberculosis
-
Application No.: US15506887Application Date: 2015-08-28
-
Publication No.: US10053446B2Publication Date: 2018-08-21
- Inventor: Hiroshi Shimizu , Yoshikazu Kawano , Shunpei Ishikawa , Yukitaka Uematsu , Toshio Shinohara , Motohiro Itotani , Yoshikazu Haraguchi , Isao Takemura , Atsunori Kaneshige , Yuya Nakai , Norimitsu Hariguchi , Yohei Hayashi , Makoto Matsumoto
- Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2014-174528 20140828
- International Application: PCT/JP2015/004371 WO 20150828
- International Announcement: WO2016/031255 WO 20160303
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/06 ; C07D215/227
Abstract:
It is an object of the present invention to provide a compound having an excellent antibacterial activity against tuberculosis bacteria, multidrug-resistant tuberculosis bacteria and/or non-tuberculous mycobacteria. Disclosed is a compound of the general formula (1): wherein each symbol is defined as described in the attached specification, or a salt thereof.
Public/Granted literature
- US20170253576A1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS Public/Granted day:2017-09-07
Information query
